Tissue Engineered Vascular Graft Recipient Interleukin 10 Status is Critical for Preventing Thrombosis.

Tissue engineered vascular grafts (TEVGs) are a promising technology, but are hindered by occlusion. Seeding with bone-marrow derived mononuclear cells (BM-MNCs) mitigates occlusion, yet the precise mechanism remains unclear. Seeded cells disappear quickly and potentially mediate an anti-inflammator...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Adv Healthc Mater
Prif Awduron: Mirhaidari, Gabriel J.M., Barker, Jenny C., Zbinden, Jacob C., Santantonio, Brevan M., Chang, Yu-Chun, Best, Cameron A., Reinhardt, James W., Blum, Kevin M., Yi, Tai, Breuer, Christopher K.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2020
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7936649/
https://ncbi.nlm.nih.gov/pubmed/33073543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adhm.202001094
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg